Previous Article | Next Article 
Applied and Environmental Microbiology, March 2000, p. 909-913, Vol. 66, No. 3
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Inactivation of Isocitrate Lyase Leads to Increased Production of
Medium-Chain-Length Poly(3-Hydroxyalkanoates) in
Pseudomonas putida
Stefan
Klinke,
Michael
Dauner,
George
Scott,
Birgit
Kessler, and
Bernard
Witholt*
Institute of Biotechnology, Swiss Federal
Institute of Technology Zurich, CH-8093 Zurich, Switzerland
Received 30 August 1999/Accepted 8 December 1999
 |
ABSTRACT |
Medium-chain-length (mcl) poly(3-hydroxyalkanoates) (PHAs) are
storage polymers that are produced from various substrates and
accumulate in Pseudomonas strains belonging to rRNA
homology group I. In experiments aimed at increasing PHA production in Pseudomonas strains, we generated an mcl PHA-overproducing
mutant of Pseudomonas putida KT2442 by transposon
mutagenesis, in which the aceA gene was knocked out. This
mutation inactivated the glyoxylate shunt and reduced the in vitro
activity of isocitrate dehydrogenase, a rate-limiting enzyme of the
citric acid cycle. The genotype of the mutant was confirmed by DNA
sequencing, and the phenotype was confirmed by biochemical experiments.
The aceA mutant was not able to grow on acetate as a sole
carbon source due to disruption of the glyoxylate bypass and exhibited
two- to fivefold lower isocitrate dehydrogenase activity than the wild
type. During growth on gluconate, the difference between the mean PHA
accumulation in the mutant and the mean PHA accumulation in the
wild-type strain was 52%, which resulted in a significant increase in
the amount of mcl PHA at the end of the exponential phase in the mutant
P. putida KT217. On the basis of a stoichiometric flux
analysis we predicted that knockout of the glyoxylate pathway in
addition to reduced flux through isocitrate dehydrogenase should lead
to increased flux into the fatty acid synthesis pathway. Therefore, enhanced carbon flow towards the fatty acid synthesis pathway increased
the amount of mcl PHA that could be accumulated by the mutant.
 |
INTRODUCTION |
Many bacteria are able to accumulate
poly(3-hydroxyalkanoates) (PHAs) as carbon and energy reserves. Because
of their potential use as biodegradable thermoplastics and as
biopolymers that can be produced from renewable resources, PHAs
have been extensively studied by academic and industrial
groups (2, 6, 30). Pseudomonads synthesize mainly
medium-chain-length (mcl) PHAs, which consist of monomers containing 6 to 14 carbon atoms (8, 14, 31). Although a few PHAs have
been developed commercially and marketed (6, 11),
widespread use of these polymers has been hindered by high production
costs (1, 19). Reduction of these costs could be achieved by
several means, including increasing the product yield
(19) or using transgenic plants for PHA production, provided
that PHA levels can be brought to 20 to 40% of the plant dry weight
(23, 24, 32).
During the past few years we have constructed several sets of mutants
of Pseudomonas putida KT2442 with the goal of altering the
carbon flux towards mcl PHAs. While most of these mutants contain
clearly reduced mcl PHA levels, a few have exhibited increased PHA
production. Preliminary analysis of one of these mutants (P. putida KT217) showed that its glyoxylate pathway was affected.
From studies on P. putida KT2442, it is known that PHA
precursors can be produced via the following three main pathways:
-oxidation, de novo fatty acid biosynthesis, and elongation of
3-hydroxyalkanoates by acetyl coenzyme A (acetyl-CoA) molecules
(12, 32). The
-oxidation pathway is active during growth
on fatty acids, whereas during growth on carbohydrate or
carbohydrate-derived substrates, such as sugars or gluconate, PHA
precursors are generated via the fatty acid synthesis pathway
(13). Therefore, when cells are grown on gluconate,
acetyl-CoA is a key intermediate of the PHA biosynthesis pathway, and
since acetyl-CoA plays an essential role in replenishing both the
citric acid cycle and the fatty acid synthesis pathway, PHA synthesis
competes with the citric acid cycle for acetyl-CoA. To decrease the
flux of acetyl-CoA into the citric acid cycle, either the level of
citrate synthase expression or the concentration of oxaloacetate should
be lowered. The intracellular concentration of oxaloacetate can be
reduced by cutting off the supply of its direct precursor, malate, by blocking the glyoxylate pathway, and/or by preventing processing of
isocitrate by reducing isocitrate dehydrogenase activity. Therefore, inactivation of the glyoxylate pathway and downregulation of isocitrate dehydrogenase should result in an increase in the overall flux of
acetyl-CoA into mcl PHA production.
In this paper we describe mutant P. putida KT217, which is
affected in the glyoxylate pathway. We also describe the potential of
isocitrate lyase and the citric acid cycle for increasing mcl PHA
levels in P. putida.
 |
MATERIALS AND METHODS |
Bacterial strains, plasmids, and growth conditions.
P.
putida KT2442 (3) is a strain which was derived from
P. putida mt2, is cured of the TOL plasmid, and is able to
produce mcl PHA from various substrates. P. putida KT217 is
an aceA knockout mutant of P. putida KT2442 that
was generated in this study. Escherichia coli JM109
(38), HB101 (25), and S17-
pir (20)
were also used, as were plasmids pGEc404 (15), pRK600
(7), pUC18 (38), and pUT mini-Tn5 tet
(7).
Pseudomonas cells were grown at 30°C in minimal medium 0.1 N E2 (17) supplemented with gluconate or a mixture of
gluconate and heptanoate as indicated below. E. coli strains
were grown at 37°C in complex Luria-Bertani (LB) medium
(25). Cells were grown in Erlenmeyer flasks and incubated at
225 rpm. The following antibiotics were added as needed: 12.5 µg of
tetracycline per ml and 30 µg of rifampin per ml. Media were
solidified with 1.5% (wt/vol) agar for plate experiments. Cell dry
weight was determined gravimetrically (10) and
spectrophotometrically at 450 nm (36). Cultures were
harvested by centrifugation and were washed with 10 mM
MgSO4. To determine amounts of PHA, the cell pellets were lyophilized.
DNA manipulation.
Basic recombinant DNA techniques, such as
preparation and purification of plasmid DNA, restriction endonuclease
digestion, agarose gel electrophoresis, and transformation of E. coli, were performed essentially as described by Sambrook et al.
(25).
Transposon mutagenesis was performed as described previously
(
7).
Southern blot analysis was performed by using a 2-kb
tet
gene fragment obtained by
SmaI digestion of pUT
mini-Tn
5 tet (
7).
The probe was labeled by using
a DIG labeling and detection kit
(Boehringer
Mannheim).
DNA sequencing and analysis of sequence data.
DNA sequencing
was performed with denatured double-stranded plasmid DNA by using an
Amersham Thermosequenase fluorescently labeled primer cycle sequencing
kit. Standard primers (pUC18/19-40 forward primer and -40 reverse
primer) and primers binding to the mini-Tn5-derived
tetracycline gene (primer A [5'-GATGTTACCCGAGAGCTTACC-3'] and primer B [5'-TAAGCGTGCATAATAAGCCCTACA-3']) were
used. A homology search was performed by using the National Center for
Biotechnology Information BLAST (Basic Local Alignment Search Tool) programs.
PHA determination.
PHA amounts and compositions were
determined as described previously (16).
Enzyme assays.
Pseudomonas cells were prepared as
spheroplasts (37) and were opened by two passages through a
French pressure cell (20,000 lb/in2). Isocitrate lyase
activity was assayed by coupling the formation of glyoxylate and the
subsequent reduction of glyoxylate to glycolate with oxidation of NADH
with lactate dehydrogenase (9). Each cuvette contained, in a
final volume of 1 ml, 50 mM MOPS (morpholine propanesulfonic acid)-NaOH
(pH 7.3), 5 mM MgCl2, 5 mM DL-isocitrate, 0.2 mM NADH, and 0.1 mg of pig heart lactate dehydrogenase per ml. The
isocitrate lyase activity level was corrected for non-isocitrate lyase-related NADH oxidation by subtracting the level of activity in
controls in which isocitrate was omitted. The level of isocitrate dehydrogenase activity was measured by monitoring the ability of the
enzyme to reduce NADP. Each cuvette contained, in a final volume of 1 ml, 50 mM MOPS-NaOH (pH 7.3), 5 mM MgCl2, 5 mM
DL-isocitrate, and 0.2 mM NADP. The isocitrate
dehydrogenase activity level was corrected for non-isocitrate
dehydrogenase-related NADP reduction by subtracting the level of
activity found in controls in which isocitrate was omitted. Protein
concentrations were measured by using the Bradford assay (Bio-Rad
Laboratories). All enzyme activities were assayed at 37°C, and
specific activities were expressed per milligram of crude supernatant
protein. One unit of enzyme activity was defined as the amount of
protein necessary to convert 1 µmol of isocitrate per min.
Flux analysis. (i) Setup of metabolic network.
The
biochemical reaction network for P. putida shown in Fig.
1 was constructed on the basis of
previously described data (29) and on the basis of the
results of a sequence analysis of the P. aeruginosa genome
in the EMP database (http://wit.mcs.anl.gov/WIT2) (27, 28).
Serial reaction steps were considered by examining lumped reactions
(several reactions were combined in one equation). The stoichiometric
matrix was formulated accordingly. Based on thermodynamics and typical
intracellular metabolite concentrations, the reactions catalyzed by the
following enzymes were considered to be physiologically irreversible:
pyruvate dehydrogenase, citrate synthase, 2-oxoglutarate synthase,
malic enzyme, malate synthase, the respiratory reaction, and
gluconokinase. Boundaries were imposed so that irreversible reactions
had nonnegative fluxes. The reaction from acetyl-CoA to mcl PHA was
assumed to consist of the appropriate reactions of the fatty acid
synthesis cycle and the polymerization reaction from 3-hydroxy acyl-CoA
to the polymer. Conversion of NADPH to NADH via the transhydrogenase
reaction was assumed to be reversible (35). The precursor
requirements for biomass formation were obtained from
Physiology of the Bacterial Cell: a Molecular Approach
(22), with the modifications proposed by Sauer et al. (26).

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 1.
Flux distribution for P. putida KT217 during
exponential growth on gluconate. The flux values (values in boxes) are
expressed as percentages of the specific gluconate uptake rate. It is
thought that malic enzyme uses NAD as a cofactor. Gluconeogenetic
reactions and the nonoxidative branch of the pentose phosphate cycle
are not shown. Abbreviations: EDP, Entner-Doudoroff pathway; EMP,
glycolysis; FS, fatty acid biosynthesis; GC, glyoxylate cycle; GNG,
gluconeogenesis; PPC, pentose phosphate cycle; TCC, citric
acid cycle; A, phosphoenolpyruvate carboxylase; B, malic enzyme; C,
pyruvate dehydrogenase; D, malate synthase; E, isocitrate lyase; F,
isocitrate dehydrogenase; G, 2-oxoglutarate synthase; T3P, triose
3-phosphate; PEP, phosphoenolpyruvate; PYR, pyruvate; ACoA, acetyl-CoA;
OAA, oxaloacetate; GLY, glyoxylate; ICI, isocitrate; SUC, succinate;
MAL, malate. FADH2 is treated like NADH.
|
|
The principles of stoichiometric flux analysis have been extensively
described previously (
33). Specific metabolite
concentrations
can be balanced according to the dynamic flux
balance
|
(1)
|
where
x is the metabolite concentration,
S
is the stoichiometric matrix,
v is the intracellular
reaction flux, and
b is the
withdrawal flux from the
reaction system. Assuming that balanced
growth occurs in the
exponential growth phase of batch cultures,
the dynamic flux balance
(equation 1) reduces to the quasi steady-state
balance
|
(2)
|
The dimension of the stoichiometric matrix was 22 × 22 with
rank 20. The carbon dioxide and the oxygen balance were excluded.
The
flux through malic enzyme was assumed to be negligible (
21),
and the glyoxylate shunt was found to be inactive in the case
of mutant
strain KT217, which reduced the dimension of the stoichiometric
matrix to 20 × 20 with rank 20, indicating that it was a determined
system. The linear equation system was solved by using the linprog
function from the MATLAB Optimization Toolbox (
5). In case
of wild-type strain KT2442, the system was underdetermined due
to an
active glyoxylate shunt, which did not allow us to solve
the system for
an unambiguous
solution.
(ii) Solving the flux model.
In order to examine the
stoichiometric dependence between fluxes of isocitrate dehydrogenase
and specific mcl PHA production in wild-type and mutant strains, the
complete system was considered without any constraints on the malic
enzyme reaction and, in the case of the wild-type strain, glyoxylate
shunt activity. In this case minimization of substrate conversion to
PHA was used as an objective function.
 |
RESULTS |
Preparation of transposon mutant P. putida KT217.
Cells that were mutagenized with the mini-Tn5 tet transposon
were screened on medium 0.1 N E2 containing 15 mM octanoate, 30 µg of
tetracycline per ml, and traces of LB medium. Colonies which grew
poorly compared to wild-type colonies were plated onto gluconate-containing medium. Cells which grew slowly on
octanoate-containing medium supplemented with traces of LB medium and
grew normally on gluconate-containing medium were selected for further
analysis. Six clones were selected from 15,000 colonies and
characterized in more detail. To determine whether the observed
phenotype of the mutants was due to insertion of mini-Tn5
tet into the bacterial chromosome, hybridization experiments were
carried out. Chromosomal DNA of the six mutants were digested with
KpnI and hybridized with the labeled fragment of the
tet gene (data not shown). Since the mutants showed
hybridization in Southern blot experiments, they were used for further
characterization. One of the putative mutants, designated KT217, was
not able to utilize acetate and other mcl fatty acids, such as hexanoic
acid or decanoic acid, as sole carbon sources and was used for further analysis.
Characterization of the genotype of KT217.
Chromosomal DNA of
mutant KT217 was digested with KpnI and ligated into
KpnI-digested pUC18. Tetracycline-resistant clones contained
an insert that was approximately 5.8 kb long. The nucleotide sequences
of the transposon flanking regions were determined by DNA sequencing.
To determine the gene or chromosomal DNA stretch into which the
mini-Tn5 tet transposon was integrated, a homology search
was performed with the nucleotide sequences obtained. The two
transposon flanking regions of KT217 exhibited the highest level of
homology to the aceA gene of E. coli (64% at the
amino acid sequence level), which indicated that we knocked out a gene encoding an isocitrate lyase. Moreover, analysis of the isocitrate lyase activities in crude extracts revealed that P. putida
KT217 contained only 1 to 5% of this enzyme activity compared to
P. putida KT2442, suggesting that there was a block in the
glyoxylate pathway (Table 1).
Determination of the in vitro activity of isocitrate dehydrogenase
revealed that the activity of mutant KT217 decreased by a factor of two
to five depending on the substrate compared with wild-type strain
KT2442 (Table 1). Apparently, inactivation of the aceA gene
not only disrupted the glyoxylate pathway but also significantly
reduced the isocitrate dehydrogenase activity.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Specific activities of isocitrate lyase and isocitrate
dehydrogenase in crude extracts of P. putida KT2442 and
P. putida KT217a
|
|
Accumulation of PHA in aceA knockout mutant KT217 grown
on gluconate.
To investigate whether the aceA mutation
affects PHA biosynthesis, we measured the growth phase-dependent PHA
accumulation of P. putida KT217 and its parent strain,
P. putida KT2442. Table 2
shows that during growth on gluconate the cell dry weight and amount of
polymer accumulated by KT217 were significantly greater at the end of
the exponential phase and in the late stationary phase than the
comparable values for wild-type strain KT2442. The difference between
the mean PHA accumulation in the mutant and the wild-type strain was
52%. In the late stationary phase the difference between the mean PHA
accumulation in the mutant and the wild-type strain was 8%. The PHA
monomer composition was relatively constant during the period studied,
and 3-hydroxydecanoate was the predominant monomer in both strains
(Table 2).
Accumulation of PHA in aceA knockout mutant KT217 grown
on mixtures of gluconate and fatty acids.
When we grew cells on
mixtures of gluconate and heptanoate, PHA accumulation and PHA monomer
composition depended on substrate ratios. Figure
2A shows that there was not much
incorporation of heptanoate-derived monomers (C7 monomers)
into PHA in the mutant and wild-type strains when cells were grown in
the presence of low heptanoate concentrations (gluconate/heptanoate
ratio, 21) due to heptanoate substrate limitation. As the heptanoate
concentration increased (gluconate/heptanoate ratios, 5 to 2),
C7 monomer incorporation into wild-type PHA increased,
while the mutant incorporated less C7 monomer into PHA than
the wild type incorporated due to an unknown effect. At a
gluconate/heptanoate ratio of 0.3, mutant cells incorporated much
smaller amounts of C7 monomers into PHA than the wild type
incorporated (Fig. 2A), indicating that there were metabolic
limitations because of limiting amounts of gluconate in combination
with aceA gene inactivation.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 2.
Incorporation of monomers into PHA by P. putida KT2442 ( ) and by aceA knockout mutant
P. putida KT217 ( ) grown on substrate mixtures containing
gluconate and heptanoate. Cells were cultivated by using the following
substrate mixtures in 0.1 N E2 minimal medium: 42 mM gluconate and 2 mM
heptanoate (gluconate/heptanoate ratio, 21), 32 mM gluconate and 6 mM
heptanoate (gluconate/heptanoate ratio, 5), 23 mM gluconate and 10 mM
heptanoate (gluconate/heptanoate ratio, 2), and 5 mM gluconate and 18 mM heptanoate (gluconate/heptanoate ratio, 0.3). Samples were harvested
after 48 h of cultivation, lyophilized, and analyzed by gas
chromatography. (A) Incorporation of C7 monomers
(3-hydroxyheptanoate) into mcl PHA relative to total cell dry weight
(cdw). (B) Total mass of Ceven monomers (3-hydroxyhexanoate,
3-hydroxyoctanoate, 3-hydroxydecanoate, and
3-hydroxydodecanoate-3-hydroxydodecenoate) incorporated
into PHA relative to total cell dry weight.
|
|
KT217 cells grown in the presence of gluconate/heptanoate ratios
between 2 and 21 produced larger amounts of PHA derived from
gluconate than the wild type produced (Fig.
2B); this
incorporated
PHA consisted of monomers with even numbers of carbon
atoms (3-hydroxyhexanoate,
3-hydroxyoctanoate, 3-hydroxydecanoate,
and 3-hydroxydodecanoate-3-hydroxydodecenoate
[Ceven]). At a
low gluconate concentration (gluconate/heptanoate
ratio, 0.3),
both wild-type and mutant strains incorporated small
amounts of
Ceven into PHA due to gluconate limitation (Fig.
2B).
Our results
indicate that gluconate-derived monomer incorporation
into PHA
was greater in mutant KT217 than in the wild type if
excess
gluconate was available (Fig.
2B). The increased incorporation
of Ceven
monomers into PHA might have been due to the
aceA knockout
in KT217 and was consistent with the greater accumulation of mcl
PHA in
KT217 than in the wild type when cells were grown on gluconate
as the
sole carbon source. However, when one of the substrates
(gluconate or
heptanoate) was present at a low concentration,
small amounts of the
corresponding monomers (C
7 monomers for a
gluconate/heptanoate ratio of 21 [Fig.
2A] and Ceven for a
gluconate/heptanoate
ratio of 0.3 [Fig.
2B]) were incorporated into
PHA in both the
mutant and the wild
type.
 |
DISCUSSION |
In this study we obtained a transposon mutant of P. putida which contained increased levels of mcl PHA. Analysis of
this mutant revealed that because the aceA gene was knocked
out, the glyoxylate pathway was inhibited and the activity of
isocitrate dehydrogenase was reduced, which resulted in increased
carbon flux towards mcl PHA.
We hypothesize that the increased mcl PHA accumulation in mutant
KT217 is caused by the following mechanism. Knockout of
the aceA gene in KT217 results in disruption of the
glyoxylate pathway. As a result of transcriptional stop elements
that flank the transposon inserted in the aceA gene,
transcription of the aceK gene encoding isocitrate
dehydrogenase kinase/phosphatase is prevented. As shown previously
(18), inactivation of the aceK gene can lead to
reduced activity of isocitrate dehydrogenase. Due to this polar effect of aceA gene knockout, the isocitrate dehydrogenase activity
in KT217 is reduced, which results in a reduction in carbon flux through the protein (34). Consequently, the flux of
acetyl-CoA into the citric acid cycle is diminished, and the flux
into the fatty acid synthesis pathway is increased, which
leads to increased amounts of mcl PHA in KT217.
Surprisingly, the reduction in isocitrate dehydrogenase activity did
not lead to reduced growth of the mutant. As a possible explanation for this result, we tested the hypothesis that the mutant
excreted less secondary metabolites (e.g., acetate) than the wild type
excreted. Since we could not detect significant amounts of metabolites
in the culture broth supernatant of either the mutant or the wild type
(data not shown), this hypothesis was not valid. We concluded that the
flux of carbon through the citrate cycle in the wild type was not a
limiting factor for growth. Presumably, other metabolites important for
growth-relevant precursor production (e.g., acetyl-CoA),
whose levels might have been increased by the aceA
mutation, led to the fast growth of the mutant.
We performed a stoichiometric flux analysis of P. putida
KT217 grown in a batch culture containing gluconate (Fig. 1). The model
predicted that there would be increased flux into PHA if the flux
through isocitrate dehydrogenase was reduced in combination with zero
flux through the glyoxylate shunt. Since experimental in vivo flux data
were not available, we used in vitro enzyme assays. This was a
reasonable approach because isocitrate dehydrogenase is one of the
rate-controlling enzymes in the citric acid cycle (34);
thus, we expected a positive correlation between activity and flux
through the enzyme. Indeed, we determined that the activity of
isocitrate dehydrogenase was reduced by a factor of 2 to 5 in the
mutant (Table 1). Thus, the stoichiometric flux analysis results
corroborated our hypothesis that there is enhanced carbon flow into mcl
PHAs in mutant KT217.
At high ratios of gluconate to heptanoate, the mutant accumulated
larger amounts of gluconate-derived PHA than the wild type accumulated
(Fig. 2B). In agreement with our pathway hypothesis, the data obtained
with mixed substrates indicate that incorporation of gluconate-derived
monomers into PHA was greater in mutant KT217 than in the wild type, if
an excess of the carbon source gluconate was available.
In summary, in this study we found that modifying the carbon flux can
help increase the amounts of bacterial products that accumulate and
therefore can be a powerful tool in biotechnological strain
improvement. However, since it is known that in cellular systems often
no or only minor phenotypic changes occur after mutation of a single
gene unless a certain set of other genes is simultaneously altered
(4), a combination of the aceA knockout with
other mutations might affect mcl PHA production even more. Therefore,
in future work we will look more closely at generating strains with
multiple mutations in order to further increase mcl PHA production in
members of the genus Pseudomonas.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the Swiss Federal Office
for Education and Science (BBW grant 96.0348) and from the Boehringer
Ingelheim Fonds to S.K. and M.D., respectively.
We thank Wouter Duetz and Uwe Sauer for helpful discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Biotechnology, Swiss Federal Institute of Technology, ETH Zurich,
Hoenggerberg HPT, CH-8093 Zurich, Switzerland. Phone: 41-1-633 3286. Fax: 41-1-633 1051. E-mail: bw{at}biotech.biol.ethz.ch.
 |
REFERENCES |
| 1.
|
Ackermann, J. U., and W. Babel.
1998.
Approaches to increase the economy of the PHB production.
Polym. Degrad. Stabil.
59:183-186[CrossRef].
|
| 2.
|
Anderson, A. J., and E. A. Dawes.
1990.
Occurence, metabolism, metabolic role, and industrial uses of bacterial polyhydroxyalkanoates.
Microbiol. Rev.
54:450-472[Abstract/Free Full Text].
|
| 3.
|
Bagdasarian, M.,
R. Lurz,
B. Ruckert,
F. C. H. Franklin,
M. M. Bagdasarian,
J. Frey, and K. N. Timmis.
1981.
Specific-purpose plasmid cloning vectors. II. Broad host range, high copy number, RSF1010-derived vectors for gene cloning in Pseudomonas.
Gene
16:237-247[CrossRef][Medline].
|
| 4.
|
Bailey, J. E.
1999.
Lessons from metabolic engineering for functional genomics and drug discovery.
Nat. Biotechnol.
17:616-618[CrossRef][Medline].
|
| 5.
|
Branch, M. A., and A. Grace.
1996.
Optimization toolbox user's guide.
A. Grace, Natick, Mass.
|
| 6.
|
Byrom, D.
1987.
Polymer synthesis by microorganisms: technology and economies.
Trends Biotechnol.
5:246-250[CrossRef].
|
| 7.
|
de Lorenzo, V.,
M. Herrero,
U. Jakubzik, and K. N. Timmis.
1990.
Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria.
J. Bacteriol.
172:6568-6572[Abstract/Free Full Text].
|
| 8.
|
de Smet, M. J.,
G. Eggink,
B. Witholt,
J. Kingma, and H. Wynberg.
1983.
Characterization of intracellular inclusions formed by Pseudomonas oleovorans during growth on octane.
J. Bacteriol.
154:870-878[Abstract/Free Full Text].
|
| 9.
|
El-Mansi, E. M. T.,
C. MacKintosh,
K. Duncan,
W. H. Holms, and H. G. Nimmo.
1987.
Molecular cloning and over-expression of the glyoxylate bypass operon from Escherichia coli ML308.
Biochem. J.
242:661-665[Medline].
|
| 10.
|
Hazenberg, W. M.
1997.
Production of poly(3-hydroxyalkanoates) by Pseudomonas oleovorans in two-liquid-phase media. Ph.D. thesis.
ETH Zurich, Zurich, Switzerland.
|
| 11.
|
Hrabak, O.
1992.
Industrial production of poly- -hydroxybutyrate.
FEMS Microbiol. Rev.
103:251-256[CrossRef].
|
| 12.
|
Huijberts, G. N. M.,
T. C. de Rijk,
P. de Waard, and G. Eggink.
1995.
13C nuclear magnetic resonance studies of Pseudomonas putida fatty acid metabolic routes involved in poly(3-hydroxyalkanoate) synthesis.
J. Bacteriol.
176:1661-1666[Abstract/Free Full Text].
|
| 13.
|
Huijberts, G. N. M.,
G. Eggink,
P. de Waard,
G. W. Huisman, and B. Witholt.
1992.
Pseudomonas putida KT2442 cultivated on glucose accumulates poly(3-hydroxyalkanoates) consisting of saturated and unsaturated monomers.
Appl. Environ. Microbiol.
58:536-544[Abstract/Free Full Text].
|
| 14.
|
Huisman, G. W.,
O. de Leeuw,
G. Eggink, and B. Witholt.
1989.
Synthesis of poly-3-hydroxyalkanoates is a common feature of fluorescent pseudomonads.
Appl. Environ. Microbiol.
55:1949-1954[Abstract/Free Full Text].
|
| 15.
|
Huisman, G. W.,
E. Wonink,
R. Meima,
B. Kazemier,
P. Terpstra, and B. Witholt.
1991.
Metabolism of poly(3-hydroxyalkanoates) (PHAs) by Pseudomonas oleovorans.
J. Biol. Chem.
266:2191-2198[Abstract/Free Full Text].
|
| 16.
|
Klinke, S.,
Q. Ren,
B. Witholt, and B. Kessler.
1999.
Production of medium chain length poly(3-hydroxyalkanoates) from gluconate in recombinant Escherichia coli.
Appl. Environ. Microbiol.
65:540-548[Abstract/Free Full Text].
|
| 17.
|
Lageveen, R. G.,
G. W. Huisman,
H. Preusting,
P. E. F. Ketelaar,
G. Eggink, and B. Witholt.
1988.
Formation of polyester by Pseudomonas oleovorans: the effect of substrate on the formation and composition of poly-(R)-3-hydroxyalkanoates and poly-(R)-3-hydroxyalkenoates.
Appl. Environ. Microbiol.
54:2924-2932[Abstract/Free Full Text].
|
| 18.
|
LaPorte, D. C.,
P. E. Thorsness, and J. Koshland.
1985.
Compensatory phosphorylation of isocitrate dehydrogenase.
J. Biol. Chem.
260:10563-10568[Abstract/Free Full Text].
|
| 19.
|
Lee, S. Y.
1996.
Bacterial polyhydroxyalkanoates.
Biotechnol. Bioeng.
49:1-14[CrossRef].
|
| 20.
|
Miller, V. L., and J. J. Mekalanos.
1988.
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants on Vibrio cholerae requires toxR.
J. Bacteriol.
170:2575-2583[Abstract/Free Full Text].
|
| 21.
|
Murai, T.,
M. Tokushige,
J. Nagai, and H. Katsuki.
1971.
Physiological functions of NAD- and NADP-linked malic enzymes in Escherichia coli.
Biochem. Biophys. Res. Commun.
43:875-881[CrossRef][Medline].
|
| 22.
|
Neidhardt, F. C.,
J. L. Ingraham, and M. Schaechter.
1990.
Physiology of the bacterial cell: a molecular approach.
Sinauer Associates, Inc., Sunderland, Mass.
|
| 23.
|
Poirier, Y.,
D. E. Dennis,
K. Klomparens, and C. Somerville.
1992.
Polyhydroxybutyrate, a biodegradable thermoplastic, produced in transgenic plants.
Science
256:520-523[Abstract/Free Full Text].
|
| 24.
|
Poirier, Y.,
C. Nawrath, and C. Somerville.
1995.
Production of polyhydroxyalkanoates, a family of biodegradable plastics and elastomers, in bacteria and plants.
Bio/Technology
13:142-150[CrossRef][Medline].
|
| 25.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 26.
|
Sauer, U.,
V. Hatzimanikatis,
H.-P. Hohmann,
M. Manneberg,
A. P. G. M. van Loon, and J. E. Bailey.
1996.
Physiology and metabolic flux of wild-type and riboflavin-producing Bacillus subtilis.
Appl. Environ. Microbiol.
62:3687-3696[Abstract].
|
| 27.
|
Selkov, E.,
S. Basmanova,
T. Gaasterland,
I. Goryanin,
Y. Gretchkin,
N. Maltsev,
V. Nenashev,
R. Overbeek,
E. Penyushkina,
L. Pronevitch,
E. Selkov, Jr., and I. Yunus.
1996.
The metabolic pathway collection from EMP: the enzymes and metabolic pathways database.
Nucleic Acids Res.
24:26-28[Abstract/Free Full Text].
|
| 28.
|
Selkov, E., Jr.,
Y. Gretchkin,
N. Mikhailova, and E. Selkov.
1998.
MPW: the metabolic pathways database.
Nucleic Acids Res.
26:43-45[Abstract/Free Full Text].
|
| 29.
|
Stanier, R. Y.,
E. A. Adelberg, and J. L. Ingraham.
1977.
General microbiology, 4th ed.
The Macmillan Press Ltd., London, United Kingdom.
|
| 30.
|
Steinbüchel, A.
1996.
PHB and other polyhydroxyalkanoic acids, p. 405-464.
In
H.-J. Rehm, and G. Reed (ed.), Biotechnology, vol. 6. VCH, Weinheim, Germany.
|
| 31.
|
Timm, A., and A. Steinbüchel.
1990.
Formation of polyesters consisting of medium-chain-length 3-hydroxyalkanoic acids from gluconate by Pseudomonas aeruginosa and other fluorescent pseudomonads.
Appl. Environ. Microbiol.
56:3360-3367[Abstract/Free Full Text].
|
| 32.
|
van der Leij, F. R., and B. Witholt.
1995.
Strategies for the sustainable production of new biodegradable polyesters in plants: a review.
Can. J. Microbiol.
41(Suppl. 1):222-238.
|
| 33.
|
Varma, A., and B. O. Palsson.
1996.
Metabolic flux balancing: basic concepts, scientific and practical use.
Bio/Technology
12:994-998.
|
| 34.
|
Voet, D., and J. G. Voet.
1990.
Biochemistry.
John Wiley & Sons, Inc., New York, N.Y.
|
| 35.
|
Voordouw, G.,
S. M. van der Vies, and A. P. N. Themmen.
1983.
Why are two different types of pyridine nucleotide transhydrogenase found in living organisms?
Eur. J. Biochem.
131:527-533[Medline].
|
| 36.
|
Witholt, B.
1972.
Method for isolating mutants overproducing nicotinamide adenine dinucleotide and its precursors.
J. Bacteriol.
109:350-364[Abstract/Free Full Text].
|
| 37.
|
Witholt, B.,
M. Boekhout,
M. Brock,
J. Kingma,
H. Heerikhuizen, and L. de Leij.
1976.
An efficient and reproducible procedure for the formation of spheroplasts from variously grown Escherichia coli.
Anal. Biochem.
74:160-170[CrossRef][Medline].
|
| 38.
|
Yanisch-Perron, C.,
J. Viera, and J. Messing.
1985.
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.
Gene
33:103-119[CrossRef][Medline].
|
Applied and Environmental Microbiology, March 2000, p. 909-913, Vol. 66, No. 3
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.